Metabolic Memory Following Metabolic Bariatric Surgery: Mechanisms, Clinical Implications, and Strategies for Long-Term Success
- 27 November 2025
- journal article
- review article
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5606-5624
Abstract
Metabolic bariatric surgery (MBS) treats severe obesity, but long-term benefits are often lost to weight regain and metabolic relapse driven by persistent molecular imprints. This narrative review synthesizes recent evidence and examines epigenetic, inflammatory, mitochondrial, and microbiota mechanisms underlying metabolic memory after MBS. Key imprints include altered adipose transcriptomes (e.g., lower IGF1 and GPX3), persistent NLRP3 inflammasome activation, and gut dysbiosis with variable, individual patterns. We highlight how these mechanisms drive clinical outcomes such as type 2 diabetes recurrence and residual cardiovascular risk, with tissue-specific epigenetic retention slowing renal and cardiac recovery. We evaluate evidence-based strategies to counteract or modulate metabolic memory. These include the strategic selection of bariatric procedure, preoperative metabolic optimization, Mediterranean diets rich in polyphenols, GLP-1/GIP co-agonists, senolytics (e.g., dasatinib + quercetin), and autologous fecal microbiome transplantation. Emerging preclinical approaches like CRISPR-dCas9 epigenetic editing and exploratory strategies like vagal neuromodulation show theoretical promise in targeting obesogenic memory pathways but remain far from clinical application. The review underscores the need for longitudinal multi-omics cohorts and metabolic memory biomarkers (e.g., PPARGC1A methylation, CCL25) to enable personalized interventions. By targeting metabolic memory proactively, MBS can evolve from weight-loss procedure to a durable reset of metabolic set points. However, it is crucial to acknowledge that many proposed strategies are derived from preliminary studies with limited sample sizes and follow-up, necessitating further validation in large-scale trials.Keywords
This publication has 63 references indexed in Scilit:
- The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysisInflammation Research, 2019
- Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 DiabetesAdvances in Nutrition, 2019
- How and why weight stigma drives the obesity ‘epidemic’ and harms healthBMC Medicine, 2018
- Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular ComplicationsDiabetes Care, 2016
- Longer-Term Physiological and Metabolic Effects of Gastric Bypass SurgeryCurrent Diabetes Reports, 2016
- American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgerySurgery for Obesity and Related Diseases, 2016
- Endocrine and Metabolic Complications After Bariatric SurgerySaudi Journal of Gastroenterology, 2015
- Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research SocietySLEEP, 2015
- Metabolic surgery: Action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literatureBest Practice & Research Clinical Gastroenterology, 2014
- Improved memory function 12 weeks after bariatric surgerySurgery for Obesity and Related Diseases, 2011